CarsonAllaria Wealth Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
CarsonAllaria Wealth Management's HALO Position: Q4 2024 in Review
CarsonAllaria Wealth Management sold out of Halozyme (HALO) in Q4 2024, closing a stake of 98 shares — an estimated $5.61K sold.
CarsonAllaria Wealth Management first reported a position in HALO in Q2 2023 and held it in 6 quarters. The position peaked at $5.61K in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.
- CarsonAllaria Wealth Management reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
- CarsonAllaria Wealth Management sold 98 Halozyme shares in Q4 2024, an estimated $5.61K.
- CarsonAllaria Wealth Management first reported a position in Halozyme in Q2 2023 and held it in 6 quarters.
- CarsonAllaria Wealth Management's Halozyme position peaked at $5.61K in Q3 2024.
- 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.
Based on CarsonAllaria Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.